Continuous Glucose Monitor
Dexcom G6 excels in effectiveness (95/100) due to robust pivotal data (MARD 9.7% n=324) and 10+ RCTs validating accuracy/A1C benefits, weighted 60%. Safety (80/100) solid in trials but deducted for post-market MAUDE volume (skin issues, malfunctions). Quality (85/100) bolstered by FDA De Novo/ISO but lacks supplement-style 3rd-party purity certs. Overall 90/100 reflects proven medical device for diabetes management vs supplements.
Dexcom G6 is an excellent FDA-approved CGM with strong evidence from pivotal trials (MARD 9.7% n=324) and multiple RCTs for accurate no-fingerstick monitoring and A1C improvements. Safety solid in controlled studies but monitor for skin reactions per MAUDE. High value for diabetics despite cost.